Ra Capital Management, L.P. Ascendis Pharma A/S Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,108,400 shares of ASND stock, worth $1.21 Billion. This represents 20.78% of its overall portfolio holdings.
Number of Shares
10,108,400Holding current value
$1.21 Billion% of portfolio
20.78%Shares
17 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.5MCall Options Held
142KPut Options Held
259K-
Westfield Capital Management CO LP Boston, MA4.96MShares$592 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$512 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$500 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$467 Million0.29% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$312 Million0.06% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.65B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...